We’re pleased to be attending BIO 2019 from June 3-6. Heidi Kingdon Jones, Global VP…
Ready to race? Come talk to us at BIO Digital from 8-12th June in our virtual drug discovery pavilion.
IRBM are an innovative research organization working across all aspects of drug discovery and early development for different modalities – small molecule, peptides and antibodies. We foster collaborations with organizations in the pharmaceutical, biotech and academic sectors to accelerate drug discovery from target validation and hit identification to candidate nomination.
Our high performance, 200 plus-strong team works at a state-of-the-art R&D facility near Rome where projects are carried out “under one roof” enabling rapid cycle times and seamless transitions between disciplines. We are a trusted partner and will go the extra mile to solve your challenges and deliver on your program goals.
Wherever you are in the drug discovery race, our winning team, at the forefront of R&D, will help drive your programs forward to the finish line. IRBM’s scientists have helped discover four marketed drugs and a further 25 compounds have gone into clinical testing in multiple therapeutic indications.
IRBM gets you to the checkered flag.